Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.32 (
phosphoenolpyruvate carboxykinase
)
4,204
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The two gluconeogenic substrains of renal epithelial cells, LLC-PK1-FBPase+ and OKGNG+, have been shown to differ markedly in their metabolism of lactate and pyruvate. OKGNG+ cells consumed lactate as well as pyruvate at high rates in contrast to LLC-PK1-FBPase+ cells, which failed to take up or utilize lactate. (Aminooxy)acetate (
AOA
), an inhibitor of transamination reactions, was used to further delineate these differences. Lactate consumption of OKGNG+ cells was significantly inhibited by
AOA
, whereas pyruvate consumption by LLC-PK1-FBPase+ cells was slightly stimulated. Growth of OKGNG+ cultures, however, could be achieved on lactate in the presence of
AOA
. From these results it was concluded that the cell strains might differ in the subcellular distribution of
phosphoenolpyruvate carboxykinase
(
PEPCK
). LLC-PK1-FBPase+ cells may express both mitochondrial and cytosolic
PEPCK
isoenzymes, whereas OKGNG+ cells express only the mitochondrial isoenzyme. This was tested by directly assaying
PEPCK
activity in subcellular fractions of the cells. In OKGNG+ cells
PEPCK
activity fractionated with the mitochondrial marker glutamate dehydrogenase; however, in LLC-PK1-FBPase+ cells two-thirds of
PEPCK
activity was found in the cytosol. In LLC-PK1-FBPase+ cells,
PEPCK
activity increased twofold on incubation in acidic culture medium (pH 6.9) for 18 h, in contrast to the
PEPCK
activity in OKGNG+ cells. Northern blot analysis using cDNA probes specific for the mitochondrial and cytosolic
PEPCK
mRNAs confirmed the enzyme activity data. In LLC-PK1-FBPase+ cells strong expression of cytosolic
PEPCK
mRNA was observed, whereas in OKGNG+ cells only very low levels could be detected.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Subcellular localization of PEPCK and metabolism of gluconeogenic substrains of renal cell lines. 786 84